We are live on ! Find out more
LMAT icon

LeMaitre Vascular

339 hedge funds and large institutions have $2.41B invested in LeMaitre Vascular in 2026 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 121 increasing their positions, 101 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 14 (+3)

196% more first-time investments, than exits

New positions opened: 71 | Existing positions closed: 24

40% more capital invested

Capital invested by funds: $1.73B → $2.41B (+$686M)

20% more repeat investments, than reductions

Existing positions increased: 121 | Existing positions reduced: 101

14% more funds holding

Funds holding: 297339 (+42)

3.23% more ownership

Funds ownership: 93.93%97.16% (+3.2%)

50% less call options, than puts

Call options by funds: $393K | Put options by funds: $786K

Holders
339
Holders Change
+42
Holders Change %
+14.14%
% of All Funds
4.17%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.05%
New
71
Increased
121
Reduced
101
Closed
24
Calls
$393K
Puts
$786K
Net Calls
-$393K
Net Calls Change
-$174K

LMAT Hedge Fund Activity: Q1 2026 in Review

339 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q1 2026, worth a combined $2.41B — up 40% from $1.73B a quarter earlier.

Buyers outnumbered sellers: 71 funds opened new LMAT positions and 24 closed out — a net gain of 47 holders — while 121 added to existing stakes and 101 trimmed.

The largest buyer was Invesco, adding an estimated $20.8M. The largest seller was Ranger Investment Management, cutting an estimated $13.2M.

  • 339 institutional investors held LeMaitre Vascular (LMAT) as of Q1 2026, up from 297 in Q4 2025.
  • Funds reported $2.41B of LeMaitre Vascular stock for Q1 2026, up 40% quarter-over-quarter.
  • 71 funds opened new LeMaitre Vascular positions in Q1 2026 and 24 closed out, a net change of +47 holders.
  • The largest LeMaitre Vascular buyer in Q1 2026 was Invesco, an estimated $20.8M added.
  • The largest LeMaitre Vascular seller in Q1 2026 was Ranger Investment Management, an estimated $13.2M sold.

Based on aggregated 13F filings for Q1 2026.